Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2024 16:15 ET | Source: Integer Holdings Corporation

Integer Holdings Corporation Announces Preliminary Unaudited Sales Results and Acquisition of Pulse Technologies

~ Preliminary unaudited full year 2023 sales increase 16% versus 2022 ~~ Acquisition adds highly differentiated micro machining capability in high growth end markets ~~ Schedules conference call for...
January 03, 2024 08:00 ET | Source: Integer Holdings Corporation

Integer to Participate in 42nd Annual J.P. Morgan Healthcare Conference

PLANO, Texas, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced participation in the upcoming 42nd Annual J.P. Morgan Healthcare Conference to be held in San...
January 11, 2022 08:00 ET | Source: Esperion Therapeutics, Inc.

Esperion Provides Preliminary Fourth Quarter 2021 Financial Results and CLEAR Outcomes Program Update

– Unprecedented CLEAR Outcomes Trial Remains On-Track for Complete Major Adverse Cardiac Events (MACE) Accumulation in 2H 2022; Achieved 85% MACE Accumulation in December – – Fourth-quarter 2021 U.S....
January 04, 2022 16:05 ET | Source: Caribou Biosciences, Inc.

Caribou Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference

BERKELEY, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...
December 21, 2020 08:00 ET | Source: Esperion Therapeutics, Inc.

Esperion to Present at the 39th Annual J.P. Morgan Healthcare Conference

ANN ARBOR, Mich., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Tim M. Mayleben, will present at the virtual 39th Annual J.P....
January 06, 2020 07:05 ET | Source: Clearside Biomedical, Inc.

Clearside Biomedical to Present at the 38th Annual J.P. Morgan Healthcare Conference

ALPHARETTA, Ga., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
January 03, 2018 16:30 ET | Source: Esperion Therapeutics, Inc.

Esperion to Participate in Fireside Chat at the 36th Annual J.P. Morgan Healthcare Conference

Fireside Chat Webcast on Wednesday, January 10, 2018 at 11:00 a.m. Pacific Time / 2:00 p.m. Eastern Time ANN ARBOR, Mich., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc....